Esophageal Varices Clinical Trial
Official title:
Evaluation of the PillCam™ Eso Capsule in the Detection of Esophageal Varices
The purpose of the study is to access the accuracy of the PillCam Eso capsule in identifying the presence of suspected esophageal disease in patients undergoing surveillance or screening for esophageal disease by standard endoscopy
The procedure that is being evaluated in this study is an esophageal capsule which is part of
the Given® Diagnostic System. This system has been developed for aiding the
gastroenterologist in diagnosing small bowel diseases or disorders, as routine methods used
today cannot explore the entire length of the small bowel in detail. It is currently
available in more than 50 countries worldwide, including the Europe, USA, Canada, Central and
South America, Australia and Asia. More than 300,000 capsules have already been ingested
worldwide. In this study, a capsule developed and approved for the esophagus (food tube
between the mouth and stomach) with two optical heads (mini cameras) will be used and
intended to take better recorded pictures of the esophagus.
During the study the study participant will undergo a capsule endoscopy and an upper
esophagoscopy. The method under investigation in this study is the capsule endoscopy.
The capsule endoscope is a small camera, about an inch long and less than half an inch wide,
which you will be asked to swallow. The camera travels from a person's mouth all the way
through their stomach and intestines and is eventually passed in the stool. The camera has a
light source (like a flash on a regular camera) and takes pictures of the esophagus. The
pictures are sent to a recorder, about the size of a wallet, using electronic signals for 20
minutes while the wireless endoscope goes through your esophagus. The disposable capsule is
passed in the stool in an average of 24 hours.
After the capsule endoscopy the study participant will undergo the esophagoscopy. An
esophagoscopy is the standard method used to view the esophagus. It involves inserting a long
flexible tube with a light and camera on the end (called an endoscope) through the mouth and
down the throat and esophagus. It may also involve the use of a sedative.
The study involves approximately two-three clinic visits.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06017102 -
Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices
|
N/A | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Recruiting |
NCT03989973 -
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
|
||
Completed |
NCT05485714 -
Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
|
||
Completed |
NCT01851252 -
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
|
Phase 1 | |
Completed |
NCT01360515 -
A Study of Disposable Transnasal Esophagoscope
|
N/A | |
Recruiting |
NCT04602663 -
Optimal Time for Follow up After Variceal Band Ligation
|
N/A | |
Recruiting |
NCT04499898 -
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
|
Phase 2/Phase 3 | |
Completed |
NCT00331188 -
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
|
Phase 3 | |
Enrolling by invitation |
NCT02767206 -
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.
|
N/A | |
Enrolling by invitation |
NCT05781828 -
Noninvasive Methods For Prediction of Esophageal Varices in Children
|
||
Not yet recruiting |
NCT05199038 -
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
|
Phase 4 | |
Recruiting |
NCT02740166 -
Preventing Recurrent Bleeding After Eradication of Esophageal Varices
|
Phase 4 | |
Completed |
NCT01893541 -
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?
|
Phase 4 | |
Terminated |
NCT00485290 -
Effect of Meal on Portal and Esophagus Variceal Pressure
|
N/A | |
Completed |
NCT01079416 -
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
|
N/A | |
Completed |
NCT01188733 -
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04254822 -
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
|
N/A | |
Recruiting |
NCT03212872 -
Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding
|
N/A | |
Completed |
NCT03748563 -
Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis
|
N/A |